COMPENDIUM ON FUNCTIONAL MEDICINE - Flipbook - Page 610
[28] Liu WY, Wang ZB, Zhang LC, Wei X, Li L. Tight junction in
blood-brain barrier: an overview of structure, regulation, and
regulator substances. CNS Neurosci Ther. 2012;18(8):609-615.
[29] Janigro D, Bailey DM, Lehmann S, Badaut J, O'Flynn R, Hirtz C,
et al. Peripheral blood and salivary biomarkers of blood-brain
barrier permeability and neuronal damage: clinical and applied
concepts. Front Neurol. 2020;11:577312.
[30] Dadas A, Washington J, Marchi N, Janigro D. Improving the
clinical management of traumatic brain injury through the
pharmacokinetic modeling of peripheral blood biomarkers. Fluids
Barriers CNS. 2016;13(1):21.
[31] Koh SX, Lee JK. S100B as a marker for brain damage and
blood-brain barrier disruption following exercise. Sports Med.
2014;44(3):369-385.
[32] Thelin EP, Nelson DW, Bellander BM. A review of the clinical
utility of serum S100B protein levels in the assessment of traumatic
brain injury. Acta Neurochir (Wien). 2017;159(2):209-225.
[33] Nitta T, Hata M, Gotoh S, et al. Size-selective loosening of the
blood-brain barrier in claudin-5-deficient mice. J Cell Biol.
2003;161(3):653-660.
[34] Campbell M, Kiang AS, Kenna PF, et al. RNAi-mediated
reversible opening of the blood-brain barrier. J Gene Med.
2008;10(8):930-947.
[35] Manley GT, Fujimura M, Ma T, et al. Aquaporin-4 deletion in
mice reduces brain edema after acute water intoxication and
ischemic stroke. Nat Med. 2000;6(2):159-163.
[36] Verkman AS, Anderson MO, Papadopoulos MC. Aquaporins:
important but elusive drug targets. Nat Rev Drug Discov.
2014;13(4):259-277.
610
